ask="3.14"
ask_size="11000"
average_daily_volume="3617390"
bid="2.90"
bid_size="600"
book_value="-1.93"
change="+0.00"
change_from_200_day_moving_average="-1.52"
change_from_50_day_moving_average="-0.03"
change_from_52_week_high="-5.93"
change_From_52_week_low="0.26"
change_in_percent="+0.00%"
close="3.09"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.21"
ebitda="-95.24M"
eps_estimate_current_year="-0.45"
eps_estimate_next_quarter="-0.19"
eps_estimate_next_year="-0.58"
ex_dividend_date="N/A"
float_shares="105666000"
high="3.14"
high_52_weeks="9.02"
last_trade_date="3/9/2017"
last_trade_price="3.09"
last_trade_size="27986"
last_trade_time="4:00pm"
low="3.05"
low_52_weeks="2.83"
market_capitalization="403.46M"
moving_average_200_day="4.61"
moving_average_50_day="3.12"
name="Merrimack Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.00"
open="3.10"
pe_ratio="N/A"
peg_ratio="-1.21"
percent_change_from_200_day_moving_average="-33.00%"
percent_change_from_50_day_moving_average="-0.83%"
percent_change_from_52_week_high="-65.72%"
percent_change_from_52_week_low="+9.19%"
previous_close="3.09"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="2.80"
revenue="144.27M"
shares_outstanding="130570000"
short_ratio="10.15"
stock_exchange="NGM"
symbol="MACK"
volume="964471"
weeks_range_52="2.83 - 9.02"
